TT  The University of Texas, MD Anderson Cancer Center

http://www.mdanderson.org/departments/techcom merc





     Office Locations:

Office of Technology Commercialization
1515 Holcombe Blvd.
Houston, TX 77030
Phone: 713-745-9604

 

Stages:

  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    The Office of Technology Commercialization (OTC) is actively identifying platform level technologies suitable for start-up company formation in order to create institutional value for intellectual property derived from novel inventions made by M. D. Anderson researchers and faculty. Since 1987, OTC has been involved in the creation of eleven affiliated companies that have raised over $300 million on the strength of M. D. Anderson technologies. Four portfolio companies listed on NASDAQ have raised over $230 million and funded $25 million in sponsored research at M. D. Anderson.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Andrew P. Dennis PhD Managing Director
    Christopher Capelli Vice President
    Peter Hoang Managing Director Office of Innovations
    Tom L. Lee Director

     

    Portfolio companies include:


      AdventRX Pharmaceuticals
        web link


      Antigenics
        web link


      ApoCell
        web link


      BioPath
        web link


      Castle Biosciences
        web link


      DNAtriX
        web link


      Idev Technologies
        web link


      MediQuest Therapeutics
        web link


      Moleculin
        web link


      NanoSpectra Biosciences
        web link


      Nuvera
        web link


      Targeted Genetics
        web link


     

    Recent News:


      There is no recent news for The University of Texas, MD Anderson Cancer Center.